|
Preserved : 2001: 23(1-12), 2002/2012: 24(1, S 1, 2-12), 2003: 25(1-24), 2004: 26(1-24, S), 2005: 27(1-14, 16-24), 2006: 28(1-24), 2007: 29(1-15, S 15, 16-24), 2008: 30(1-24, SPECIAL EDITION: A SUPPLEMENT TO), 2009: 31(1, Sup 1 15, Sup 1 18, 2-3, SPECIAL EDITION SUPPLEMENT 3, 4-24), 2010: 32(1, Sup 1 12, Sup 1 15, Sup 1 16, Sup 1 20, Sup 1 22, Sup 1 3, Sup 1 4, Sup 1 7, Sup 1 8, 2-24), 2011: 33(1, Sup 1 15, Sup 1 20, 2-24), 2012: 34(1, s1 6, 2-24), 2013: 35(1-Meeting Roundup: GU Cancers Symposium 9, 11-24, SABCS Meeting Reporter Special Edition S), 2014: 36(1-24), 2015: 37(1-24, Meeting Reporter 37th Annual San Antonio Breast Cancer Symposium 3), 2016: 38(1-24, Meeting Reporter 38th Annual San Antonio Breast Cancer Symposium 3), 2017: 39(1-24, Meeting Reporter 39th Annual San Antonio Breast Cancer Symposium 3), 2018: 40(1-24, FOCUS: 40th Annual San Antonio Breast Cancer Symposium 3), 2019: 41(1-24, Meeting Reporter 2018 ASH Annual Meeting Sickle Cell Disease Focus 3), 2020: 42(1-24, Meeting Reporter ESMO Virtual Congress 2020 Ovarian Cancer Focus 22), 2021: 43(1-HemOnc Times S4, 6-10, S 10, HemOnc Times, 11-16, S 16, HemOnc Times, 17-19, S 19, FOCUS: 2021 Research for Breast Cancer Treatment & Awareness, 20-22, S 22, HemOnc Times, 23-24, FOCUS: 2021 American Society of Clinical Oncology Annual Meeting Breast Cancer Research S15, FOCUS: 2021 Research for Breast Cancer Treatment & Awareness S19), 2022: 44(1-HemOnc Times S4, S 4, HemOnc Times, 5-10, S 10, HemOnc Times, 11-16, S 16, HemOnc Times, 17-22, S 22, HemOnc Times, 23-24), 2023: 45(1-4, S 4, HemOnc Times, 5-10, S 10, HemOnc Times, 11-16, S 16, HemOnc Times, 17-22, S 22, HemOnc Times, 23-24), 2024: 46(1-12), 2025: 47(1-12), 2026: 48(1-2)
|
